Aarti Pharmalabs Past Earnings Performance
Past criteria checks 4/6
Aarti Pharmalabs has been growing earnings at an average annual rate of 35.1%, while the Pharmaceuticals industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 0.2% per year. Aarti Pharmalabs's return on equity is 12.8%, and it has net margins of 11.6%.
Key information
35.1%
Earnings growth rate
39.8%
EPS growth rate
Pharmaceuticals Industry Growth | 17.5% |
Revenue growth rate | 0.2% |
Return on equity | 12.8% |
Net Margin | 11.6% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Aarti Pharmalabs makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 19,497 | 2,253 | 1,508 | 0 |
31 Mar 24 | 18,526 | 2,169 | 1,448 | 0 |
31 Dec 23 | 18,319 | 1,945 | 1,394 | 0 |
30 Sep 23 | 18,548 | 1,895 | 1,380 | 0 |
30 Jun 23 | 19,462 | 1,887 | 1,325 | 0 |
31 Mar 23 | 19,452 | 1,935 | 1,349 | 0 |
31 Dec 22 | 20,601 | 2,118 | 1,391 | 0 |
30 Sep 22 | 21,885 | 2,252 | 1,469 | 0 |
30 Jun 22 | 16,573 | 1,741 | 1,156 | 0 |
31 Mar 22 | 11,999 | 1,223 | 852 | 0 |
31 Mar 21 | 0 | 0 | 0 | 0 |
Quality Earnings: AARTIPHARM has high quality earnings.
Growing Profit Margin: AARTIPHARM's current net profit margins (11.6%) are higher than last year (9.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AARTIPHARM's earnings have grown significantly by 35.1% per year over the past 5 years.
Accelerating Growth: AARTIPHARM's earnings growth over the past year (19.4%) is below its 5-year average (35.1% per year).
Earnings vs Industry: AARTIPHARM earnings growth over the past year (19.4%) exceeded the Pharmaceuticals industry 19.3%.
Return on Equity
High ROE: AARTIPHARM's Return on Equity (12.8%) is considered low.